Pathophysiology of acute graft-versus-host disease - PubMed (original) (raw)
Review
doi: 10.1002/hon.716.
Affiliations
- PMID: 14735553
- DOI: 10.1002/hon.716
Free article
Review
Pathophysiology of acute graft-versus-host disease
Pavan Reddy. Hematol Oncol. 2003 Dec.
Free article
Abstract
Graft-versus-host disease (GVHD) has been the primary limitation to the wider application of allogeneic bone marrow transplantation (BMT). The pathophysiology of acute GVHD is complex and can be conceptualized to be a three-step process based on murine studies. In step 1, the conditioning regimen leads to the damage and activation of host tissues and induces the secretion of inflammatory cytokines. As a consequence, the expression of MHC antigens and adhesion molecules is increased enhancing the recognition of host alloantigens by donor T cells. Donor T-cell activation in step 2 is characterized by donor T cell interaction with host APCs and subsequent proliferation, differentiation and secretion of cytokines. Cytokines such as IL-2 and IFN-gamma enhance T-cell expansion, induce cytotoxic T cells (CTL) and natural killer (NK) cell responses and prime additional mononuclear phagocytes to produce TNF-alpha and IL-1. These inflammatory cytokines in turn stimulate production of inflammatory chemokines, thus recruiting effector cells into target organs. In step 3, effector functions of mononuclear phagocytes are triggered via a secondary signal provided by lipopolysaccharide (LPS) that leaks through the intestinal mucosa damaged during step 1. This mechanism may result in the amplification of local tissue injury and further promotion of an inflammatory response, which, together with the CTL and NK components, leads to target tissue destruction in the transplant host. The following review discusses the three-step process of the pathophysiology of experimental acute GVHD.
Copyright 2003 John Wiley & Sons, Ltd.
Similar articles
- Immunobiology of acute graft-versus-host disease.
Reddy P, Ferrara JL. Reddy P, et al. Blood Rev. 2003 Dec;17(4):187-94. doi: 10.1016/s0268-960x(03)00009-2. Blood Rev. 2003. PMID: 14556773 Review. - The role of cytokines in acute graft-versus-host disease.
Hill GR, Krenger W, Ferrara JL. Hill GR, et al. Cytokines Cell Mol Ther. 1997 Dec;3(4):257-66. Cytokines Cell Mol Ther. 1997. PMID: 9740354 Review. - The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.
Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. Cooke KR, et al. J Endotoxin Res. 2002;8(6):441-8. doi: 10.1179/096805102125001046. J Endotoxin Res. 2002. PMID: 12697087 Review. - The pathophysiology of acute graft-versus-host disease.
Jaksch M, Mattsson J. Jaksch M, et al. Scand J Immunol. 2005 May;61(5):398-409. doi: 10.1111/j.1365-3083.2005.01595.x. Scand J Immunol. 2005. PMID: 15882431 Review.
Cited by
- Tetramerization of pyruvate kinase M2 attenuates graft-versus-host disease by inhibition of Th1 and Th17 differentiation.
Wang M, Li QJ, Zhao HY, Zhang JL. Wang M, et al. Hum Cell. 2024 May;37(3):633-647. doi: 10.1007/s13577-024-01033-6. Epub 2024 Feb 28. Hum Cell. 2024. PMID: 38416276 - Novel therapies for graft versus host disease with a focus on cell therapies.
Zeiser R, Ringden O, Sadeghi B, Gonen-Yaacovi G, Segurado OG. Zeiser R, et al. Front Immunol. 2023 Oct 5;14:1241068. doi: 10.3389/fimmu.2023.1241068. eCollection 2023. Front Immunol. 2023. PMID: 37868964 Free PMC article. Review. - Advances in Imaging of Inflammation, Fibrosis, and Cancer in the Gastrointestinal Tract.
Harold KM, MacCuaig WM, Holter-Charkabarty J, Williams K, Hill K, Arreola AX, Sekhri M, Carter S, Gomez-Gutierrez J, Salem G, Mishra G, McNally LR. Harold KM, et al. Int J Mol Sci. 2022 Dec 17;23(24):16109. doi: 10.3390/ijms232416109. Int J Mol Sci. 2022. PMID: 36555749 Free PMC article. Review. - Enforced mesenchymal stem cell tissue colonization counteracts immunopathology.
García-Bernal D, Blanquer M, Martínez CM, García-Guillén AI, García-Hernández AM, Carmen Algueró M, Yáñez R, Lamana ML, Moraleda JM, Sackstein R. García-Bernal D, et al. NPJ Regen Med. 2022 Oct 19;7(1):61. doi: 10.1038/s41536-022-00258-z. NPJ Regen Med. 2022. PMID: 36261464 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous